Palvella Therapeutics, Inc.
Palvella Therapeutics, Inc. (PVLA) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · PVLA · as of Sep 30, 2025
Ownership Breakdown
102
Institutional Holders
▲ 37 vs Q2
$534.47M
Total Inst. Value
▲ $401.26M vs Q2
11.84M
Shares Outstanding
freeFloat 62.47%
8.53M
13F Shares Held
▲ 2.62M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
PVLA largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BVF INC/IL pharmaceutical preparations | 1.16M | 10.51% | 10.51% | $72.80B | Nov 14, 2025 | ▲ 464.7K |
SUVRETTA CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 822.4K | 7.44% | 7.44% | $51.56B | Nov 14, 2025 | ▲ 107.9K |
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. pharmaceutical preparations | 722.4K | 6.54% | 6.54% | $45.29B | Nov 14, 2025 | — held |
FIRST LIGHT ASSET MANAGEMENT, LLC pharmaceutical preparations | 541.5K | 4.90% | 4.90% | $33.95B | Nov 14, 2025 | NEW |
VANGUARD GROUP INC pharmaceutical preparations | 494.7K | 4.48% | 4.48% | $31.01B | Nov 7, 2025 | ▲ 330.8K |
BLACKROCK, INC. pharmaceutical preparations | 487.6K | 4.41% | 4.41% | $30.57B | Nov 12, 2025 | ▲ 42.6K |
PERCEPTIVE ADVISORS LLC pharmaceutical preparations | 395.1K | 3.57% | 3.57% | $24.77B | Nov 14, 2025 | NEW |
WOODLINE PARTNERS LP pharmaceutical preparations | 345.7K | 3.13% | 3.13% | $21.68B | Nov 14, 2025 | ▼ 99.9K |
FEDERATED HERMES, INC. pharmaceutical preparations | 339.0K | 3.07% | 3.07% | $21.25B | Nov 3, 2025 | NEW |
POINT72 ASSET MANAGEMENT, L.P. pharmaceutical preparations | 317.3K | 2.87% | 2.87% | $19.89B | Nov 14, 2025 | NEW |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
16
Increased
+1.66M shares17
New Positions
first time holders12
Decreased
−667.9K shares0
Sold Out
fully exitedNet shares change (top 50)
+996.5K
+1.66M / −667.9K
Net new holders
+21
17 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
PVLA insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
5
Buy transactions
12
Sell transactions
0.42
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Goin Kathleen Chief Operating Officer | May 20, 2026 | Sale | 3,363 | $110.35 | $371.1K | 939 | Form 4 ↗ |
Goin Kathleen Chief Operating Officer | May 20, 2026 | Sale | 891 | $111.30 | $99.2K | 48 | Form 4 ↗ |
Goin Kathleen Chief Operating Officer | May 20, 2026 | Sale | 48 | $111.89 | $5.4K | 0 | Form 4 ↗ |
Goin Kathleen Chief Operating Officer | Apr 15, 2026 | Sale | 1,502 | $125.96 | $189.2K | 2.8K | Form 4 ↗ |
Goin Kathleen Chief Operating Officer | Apr 15, 2026 | Sale | 1,500 | $127.13 | $190.7K | 1.3K | Form 4 ↗ |
Goin Kathleen Chief Operating Officer | Apr 15, 2026 | Sale | 561 | $128.23 | $71.9K | 739 | Form 4 ↗ |
Goin Kathleen Chief Operating Officer | Apr 15, 2026 | Sale | 639 | $129.17 | $82.5K | 100 | Form 4 ↗ |
Goin Kathleen Chief Operating Officer | Apr 15, 2026 | Sale | 100 | $130.33 | $13.0K | 0 | Form 4 ↗ |
Doux John director | Apr 13, 2026 | Award | 6,000 | $129.00 | $774.0K | 6.0K | Form 4 ↗ |
JENKINS GEORGE M director | Mar 30, 2026 | Purchase | 445 | $112.30 | $50.0K | 187.6K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Palvella Therapeutics, Inc. (PVLA) is primarily owned by institutional investors, who hold approximately 72.0% of total shares outstanding. Company insiders own approximately 37.53%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of Palvella Therapeutics, Inc. is BVF INC/IL, holding approximately 1.16 million shares — equal to 10.51% of outstanding shares — as of September 30, 2025.
A total of 102 institutional investors currently hold PVLA stock, with a combined institutional value of approximately $534,466,075 as of the most recent 13F filing period.
Frequently asked questions
PVLA ownershipPalvella Therapeutics, Inc. (PVLA) is primarily owned by institutional investors, who hold approximately 72.0% of shares. The largest shareholder is BVF INC/IL with a 10.51% stake. Company insiders hold 37.53%. Data sourced from SEC Form 13F as of September 30, 2025.